H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Census population 486,051. Nebraska Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Omaha clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Omaha storefront.
Growth Factor Therapy for Tissue Repair in Omaha, NE for clinics & physicians. Growth factor therapy produ… Compliance support & pricing — contact Hawk Medical.
Omaha is a city of 250k–500k (486,051 Census). CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Adult arthritis here is 21.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)J5 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Omaha is 10.2% or not. PLACES is planning data. The LCD is the claim.
If you already buy growth factor therapy elsewhere, use this page as a check: homologous-use language, current WPS Government Health Administrators article IDs, and PLACES 10.2% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 10.2% of adults — 1.8 points below the U.S. 12% figure. Obesity is 37.5%; arthritis is 21.4%. That is place-level BRFSS modeling, not a clinic census and not a Omaha trial.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what J5 reviewers and surveyors expect — not a brochure.
Often yes, which is the point of vendor consolidation. Keep DME delivery tickets and HCT/P lot files separate so a Nebraska audit trail stays clean.
Body copy and schema dateModified follow a pinned content version date, not a daily timestamp. CDC and CMS figures are cited to the public reports named on the page. Recheck MAC LCDs before each utilization change — those move faster than a landing page.
If you operate in Nebraska and another MAC state, say it on the first call. J5 will not port 1:1. We would rather split utilization than watch a sister clinic copy Omaha tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Omaha, NE.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Omaha is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Omaha — 1.8 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Nebraska Part B wound biologics follow this contractor (siblings: IA, KS, MO). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Omaha. Useful for joint-program math; still needs a diagnosis and privileging.
No Omaha storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.